Profiel
Mr. Ashley A. Woodcock is a Chairman at Axalbion SA and a Chairman at Axalbion Therapeutics Ltd. He is on the Board of Directors at North West Lung Centre.
Mr. Woodcock was previously employed as a Non-Executive Chairman by Reacta Biotech Ltd.
Actieve functies van Ashley Arthur Woodcock
| Bedrijven | Functie | Begin |
|---|---|---|
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services | Directeur/Bestuurslid | - |
Axalbion SA | Voorzitter | - |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Voorzitter | - |
Eerdere bekende functies van Ashley Arthur Woodcock
| Bedrijven | Functie | Einde |
|---|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Oprichter | 19-02-2026 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Commercial Services |
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services | Health Services |
Axalbion SA | |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Health Technology |
















